Page last updated: 2024-11-04

risedronic acid and Stroke

risedronic acid has been researched along with Stroke in 4 studies

Risedronic Acid: A pyridine and diphosphonic acid derivative that acts as a CALCIUM CHANNEL BLOCKER and inhibits BONE RESORPTION.

Stroke: A group of pathological conditions characterized by sudden, non-convulsive loss of neurological function due to BRAIN ISCHEMIA or INTRACRANIAL HEMORRHAGES. Stroke is classified by the type of tissue NECROSIS, such as the anatomic location, vasculature involved, etiology, age of the affected individual, and hemorrhagic vs. non-hemorrhagic nature. (From Adams et al., Principles of Neurology, 6th ed, pp777-810)

Research Excerpts

ExcerptRelevanceReference
"After patients with osteoporosis are identified, the challenge is to treat them appropriately."2.47Treatments for osteoporosis in people with a disability. ( Smith, EM, 2011)
"Neurological diseases, including Alzheimer's disease, stroke, and Parkinson's disease have been reported to increase the risk for fractures."2.44Efficacy of risedronate against hip fracture in patients with neurological diseases: a meta-analysis of randomized controlled trials. ( Iwamoto, J; Matsumoto, H; Takeda, T, 2008)

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's3 (75.00)29.6817
2010's1 (25.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Smith, EM1
Sato, Y1
Iwamoto, J2
Kanoko, T1
Satoh, K1
Poole, KE1
Warburton, EA1
Reeve, J1
Matsumoto, H1
Takeda, T1

Reviews

2 reviews available for risedronic acid and Stroke

ArticleYear
Treatments for osteoporosis in people with a disability.
    PM & R : the journal of injury, function, and rehabilitation, 2011, Volume: 3, Issue:2

    Topics: Bone Density; Bone Density Conservation Agents; Diphosphonates; Disabled Persons; Etidronic Acid; Hu

2011
Efficacy of risedronate against hip fracture in patients with neurological diseases: a meta-analysis of randomized controlled trials.
    Current medical research and opinion, 2008, Volume: 24, Issue:5

    Topics: Age Distribution; Aged; Aged, 80 and over; Alzheimer Disease; Bone Density Conservation Agents; Conf

2008

Trials

1 trial available for risedronic acid and Stroke

ArticleYear
Risedronate therapy for prevention of hip fracture after stroke in elderly women.
    Neurology, 2005, Mar-08, Volume: 64, Issue:5

    Topics: Accidental Falls; Aged; Bone Density; Bone Density Conservation Agents; Calcium; Double-Blind Method

2005

Other Studies

1 other study available for risedronic acid and Stroke

ArticleYear
Risedronate therapy for prevention of hip fracture after stroke in elderly women.
    Neurology, 2005, Nov-08, Volume: 65, Issue:9

    Topics: Accidental Falls; Aged; Bone Density Conservation Agents; Causality; Clinical Trials as Topic; Etidr

2005